Track topics on Twitter Track topics that are important to you
Tasly Biopharma paid $48 million in stock to buy out its China JV partner Transgene (P: TNG), which holds
Stock Symbol: (SHA: 600535)
Share this with colleagues:
Original Article: Tasly Biopharma Pays $48 Million to Buy Out JV Partner, TransgeneNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...